Treatment of Advanced Mesothelioma with the Recombinant Adenovirus H5.010RSVTK: A Phase 1 Trial (BB-IND 6274)
- 20 October 1996
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 7 (16) , 2047-2057
- https://doi.org/10.1089/hum.1996.7.16-2047
Abstract
The only peer-reviewed journal focused on the rapidly moving field of 3D printing and related technologies, providing comprehensive coverage of academic research and industrial and commercial developments that have applications in medicine, education, food, and architecture.This publication has 12 references indexed in Scilit:
- Treatment of Experimental Human Mesothelioma Using Adenovirus Transfer of the Herpes Simplex Thymidine Kinase GeneAnnals of Surgery, 1995
- Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesotheliomaThe Annals of Thoracic Surgery, 1994
- Regression of established macroscopic liver metastases after in situ transduction of a suicide gene.Proceedings of the National Academy of Sciences, 1993
- Gene therapy: adenovirus vectorsCurrent Opinion in Genetics & Development, 1993
- The Basic Science of Gene TherapyScience, 1993
- Multiple transduction as a means of preserving ganciclovir chemosensitivity in sarcoma cells carrying retrovirally transduced herpes thymidine kinase genesCancer Letters, 1992
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992
- Curability of Tumors Bearing Herpes Thymidine Kinase Genes Transfered by Retroviral VectorsJNCI Journal of the National Cancer Institute, 1990
- Malignant mesothelioma 1982: Review of 4710 published casesRespiratory Medicine, 1983
- Surgical treatment of pleural mesotheliomaThe Journal of Thoracic and Cardiovascular Surgery, 1982